Maitri Enterprises Peer Comparison

BSE: 513430

₹31.16

₹-1.60 (-4.88%)

As on 11-Nov-2026IST

Market cap

₹14 Cr

Revenue (TTM)

₹33 Cr

P/E Ratio

10.8

P/B Ratio

2.4

Div. Yield

0 %

Edit

	Maitri Enterprises	Entero Health	Medi-Caps	Vivanza Bioscience	Emcure Pharmaceuticals
Market cap (₹ Cr)	14	8,733	28	6	42,416
Revenue (₹ Cr)	33	7,644	16	72	10,234
Net Profit (₹ Cr)	1.27	191.80	-0.05	0.03	1,092.67
Net Margin (%)	3.86	2.50	-0.22	0.04	10.67
RoE (%)	23.32	8.35	-0.04	0.64	21.65
Price to Earnings	10.77	62.67	--	217.78	38.79
Price-To-Book	2.43	4.91	0.25	1.27	7.94

Income Statement (₹ Cr)

	Maitri Enterprises	Entero Health	Medi-Caps	Vivanza Bioscience	Emcure Pharmaceuticals
Operating Revenue	32.61	7,644.02	16.31	72.32	10,234.10
Total Income	32.91	7,659.63	22.77	72.75	10,245.27
Total Expenditure	29.28	7,282.55	20.93	72.18	8,141.47
EBITDA	3.33	361.47	-4.62	0.14	2,092.63
Depreciation	0.09	50.02	1.88	0.02	430.12
EBIT	3.25	311.44	-6.50	0.12	1,662.51
Interest	0.48	75.03	0.00	0.31	151.49
Other Income	0.31	15.62	6.46	0.44	11.17
Exceptional Items	0.00	-8.18	0.00	0.00	-27.85
Profit before Tax	3.07	243.85	-0.03	0.25	1,494.35
Provision for Tax	0.38	52.05	0.02	0.22	401.68
Profit after Tax	2.69	191.80	-0.05	0.03	1,092.67

	Maitri Enterprises	Entero Health	Medi-Caps	Vivanza Bioscience	Emcure Pharmaceuticals
Shareholder's Funds	7.51	1,781.11	111.44	4.64	5,344.04
Minority Interest	0.00	-52.45	0.00	0.00	0.82
Non-Current Liabilities	2.21	343.92	1.11	2.77	980.81
Current Liabilities	6.94	1,652.87	1.77	21.57	3,838.93
Total Liabilities	--	2,702.52	125.42	16.45	8,121.73

	Maitri Enterprises	Entero Health	Medi-Caps	Vivanza Bioscience	Emcure Pharmaceuticals
Non-Current Assets	7.51	927.95	67.57	1.74	3,542.74
Current Assets	9.09	2,772.72	46.02	26.64	6,027.59
Total Assets	--	2,702.52	125.42	16.45	8,121.73
Total Debt*	--	298.81	0.00	8.65	731.70
Net Current Assets	2.15	1,119.86	44.25	5.07	2,188.66
Contingent Liabilities	--	4.01	--	--	393.94

	Maitri Enterprises	Entero Health	Medi-Caps	Vivanza Bioscience	Emcure Pharmaceuticals
Cash From Operating Activities	--	-76.87	5.07	-2.50	851.71
Cash Flow from Investing Activities	--	219.80	-4.98	-0.01	-94.00
Cash from Financing Activities	--	-73.66	--	2.46	-813.96
Net Cash Inflow / Outflow	--	69.27	0.09	-0.05	-56.25

	Maitri Enterprises	Entero Health	Medi-Caps	Vivanza Bioscience	Emcure Pharmaceuticals
ROCE (%)	--	9.16	-0.66	-2.74	22.49
ROE (%)	38.53	8.35	-0.04	0.64	21.65
ROA (%)	16.96	5.71	-0.04	0.07	11.17
EBIT Margin (%)	9.96	4.07	-39.83	0.16	16.24
Net Margin (%)	8.18	2.50	-0.22	0.04	10.67
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Maitri Enterprises	Entero Health	Medi-Caps	Vivanza Bioscience	Emcure Pharmaceuticals
Revenue Growth (%)	18.48	34.75	3.98	9.11	21.12
EBIT Growth (%)	480.86	77.19	35.27	236.47	32.84
Net Profit Growth (%)	468.90	50.19	99.13	109.57	33.33
EPS Growth (%)	139.83	31.10	99.13	109.57	38.63
Book Value Growth (%)	--	5.11	0.24	-14.53	50.94

	Maitri Enterprises	Entero Health	Medi-Caps	Vivanza Bioscience	Emcure Pharmaceuticals
Price / Earnings	5.09	60.19	-561.14	202.76	38.06
Price / Book Value	1.82	4.91	0.25	1.27	7.94
Dividend Yield (%)	0.00	0.00	0.00	0.00	0.16
EV/EBITDA	6.05	24.92	-0.78	114.33	20.77
Market Cap (₹ Cr)	--	4,944.94	51.76	7.96	20,327.45

	Maitri Enterprises	Entero Health	Medi-Caps	Vivanza Bioscience	Emcure Pharmaceuticals
Debt to Equity	0.28	0.11	0.00	0.60	0.10
Short term debt to equity ratio	--	0.17	--	1.34	0.11
Current Ratio	1.31	1.68	26.03	1.24	1.57
Quick Ratio	0.42	1.15	24.15	1.08	0.92
Interest Coverage	7.40	4.25	-16.63	1.80	10.86

	Maitri Enterprises	Entero Health	Medi-Caps	Vivanza Bioscience	Emcure Pharmaceuticals
Debtors to sales (%)	3.91	19.11	41.01	27.61	26.69
Asset Turnover	2.05	2.27	0.14	1.84	1.05
Receivable days	--	51.78	140.45	481.83	87.83
Inventory Days	--	38.71	64.01	104.96	78.64
Payable days	--	24.83	63.40	290.39	174.97
Cash Conversion Cycle	--	65.66	141.06	296.40	-8.50

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.